People

Sharon Huang

Sharon Huang invests at US Tau Ventures. She previously worked on pharmaceutical strategy at Novartis and software for protein and genomic sequencing at Chan Zuckerberg Biohub. She studied computer science and epidemiology at Stanford and is continuing medical training at Mount Sinai. The current team page publishes Principal; the January 2026 newsletter calls her Vice President, without an assumed promotion date.